<DOC>
	<DOCNO>NCT01778192</DOCNO>
	<brief_summary>Adequate bowel cleanse important completeness colonoscopy detection colon polyp . Inadequate bowel preparation lead long duration colonoscopy obscure mucosal visualization result missed lesion . Bowel cleanse agent simply classify large volume , iso-osmotic polyethylene glycol ( PEG ) base solution small volume osmotically active agent , sodium picosulphate magnesium citrate ( SPMC ) . There rare report compare directly conventional polyethylene glycol ( PEG ) solution sodium picosulphate magnesium citrate ( SPMC ) bowel preparation korea . The aim study compare efficacy , safety , tolerability different regimen SPMC PEG solution .</brief_summary>
	<brief_title>A Randomized Prospective Trial Comparing Polyethylene Glycol Sodium Picosulphate With Magnesium Citrate</brief_title>
	<detailed_description>1 . Study design : endoscopist-blinded , prospective , randomize control trial 2 . Subjects 1 . Entry criterion : Male female patient , age between18 75 year undergoing elective outpatient colonoscopy eligible study . 2 . Exclusion criterion : gastrointestinal obstruction perforation , toxic megacolon , severe uncontrolled inflammatory bowel disease , previous colorectal resection , congestive heart failure , recent acute myocardial infarction unstable angina , uncontrolled arterial hypertension , renal insufficiency glomerular filtration rate &lt; 60 ml/minute/1.73 m2 , liver cirrhosis ascites , pregnancy , lactation , history hypersensitivity bowel cleanse agent . 3 . Sampling design : Consecutive recruitment consent patient 4 . Variables Predictor 1. group 1 ( day PEG ) receive 4 L PEG 6 hour procedure day colonoscopy 2. group 2 ( split PEG ) receive 2 L PEG 6:00 p.m even colonoscopy 2 L PEG 4-6 hour procedure 3. group 3 ( SPMC 2 ) receive one sachet SPMC 6 p.m even colonoscopy another sachet SPMC 4-6 hour procedure ; 4. group 4 ( SPMC 3 ) receive one sachet SPMC 6 p.m sachet 9 p.m even colonoscopy another sachet 4-6 hour procedure . 5 . Primary Outcome : Quality bowel preparation ( Ottawa scale ) 6 . Secondary Outcome : Tolerability , palatability , side effect cleanse agent</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Picosulfate sodium</mesh_term>
	<mesh_term>Magnesium citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Male female patient , age between18 75 year undergoing elective outpatient colonoscopy eligible study gastrointestinal obstruction perforation , toxic megacolon , severe uncontrolled inflammatory bowel disease , previous colorectal resection , congestive heart failure , recent acute myocardial infarction unstable angina , uncontrolled arterial hypertension , renal insufficiency glomerular filtration rate &lt; 60 ml/minute/1.73 m2 , liver cirrhosis ascites , pregnancy , lactation , history hypersensitivity bowel cleanse agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Bowel preparation</keyword>
	<keyword>Polyethylene glycol</keyword>
	<keyword>Sodium picosulphate</keyword>
</DOC>